Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Follicular

Explore clinical trials studying Lymphoma, Follicular. Study availability and eligibility vary by location and protocol.

1,362 public trials 202 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Follicular trial results

Completed

Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients

NCT03610724

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +17 more
Locations
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • UCSF Medical Center San Francisco, California, United States
  • Johns Hopkins Oncology Center ORA Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Dept.of DFCI Boston, Massachusetts, United States
View all 26 locations
View Trial Details
Completed

Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies

NCT03424603

Conditions
B Cells--Tumors, B-cell Lymphoma, Blood Protein Disorders, +26 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Oncology Associates, PC--HOPE Division Tucson, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
View all 22 locations
View Trial Details
Completed

Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy

NCT03721172

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +15 more
Locations
  • Total Skin & Beauty Dermatology Center Birmingham, Alabama, United States
  • Johnson Dermatology Clinic Fort Smith, Arkansas, United States
  • Northwest Arkansas Clinical Trials Center, PLLC / Hull Dermatology Rogers, Arkansas, United States
  • Dermatology Research Associates Los Angeles, California, United States
View all 64 locations
View Trial Details
Completed

Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma

NCT00112931

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Queen Elizabeth Hospital Adelaide, Australia
  • Royal Adelaide Hospital Adelaide, Australia
  • Ashford Cancer Centre Black Forest, Australia
  • Boxhill Hospital Box Hill, Australia
View all 72 locations
View Trial Details

Related conditions